Shares in Moderna and Novavax fell in premarket trading Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some ...
Just a few years since pioneering a Covid-19 vaccine, Moderna faces a hostile political environment and a looming patent problem. We recently compiled a list of the 12 Most Promising Biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results